FIELD: biotechnology.
SUBSTANCE: invention relates to oxindole compounds of the formula (I), wherein of R1, R2a, R2b, L1, L2, Ar, Y values are defined in the claim, which can be used for treatment of CCR(9)-mediated pathological conditions or diseases.
EFFECT: invention can be used for treatment of CCR(9)-mediated pathological conditions or diseases.
43 cl, 1 tbl, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TETRAZOLE-CONTAINING INHIBITORS OF APOPTOTIC SIGNAL-REGULATING KINASE 1 AND METHODS OF THEIR USE | 2019 |
|
RU2807545C2 |
| HETEROARYL-BIPHENYL AMINES FOR TREATING PD-L1 DISEASES | 2020 |
|
RU2837843C1 |
| 2-((4-(4-(BENZYLOXY)PYRIMIDIN-2-YL)PIPERAZIN-1-YL)METHYL)-1H-BENZO[d]IMIDAZOLE DERIVATIVES AS LOW-MOLECULAR GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS | 2024 |
|
RU2838323C1 |
| QUATERNARY AMMONIUM COMPOUNDS BASED ON 3-HYDROXYPYRIDINE WITH ANTIBACTERIAL ACTIVITY | 2021 |
|
RU2778507C1 |
| 1-THIO-D-GLUCITOL DERIVATIVES | 2006 |
|
RU2387649C2 |
| TETRAHYDROPYRANYL-CYCLOPENTYL-TETRAHYDROPYRIDOPYRIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | 2003 |
|
RU2285004C2 |
| 5-5 CONDENSED RINGS AS C5a INHIBITORS | 2018 |
|
RU2780322C2 |
| BICYCLIC HETEROAROMATIC RING DERIVATIVE | 2019 |
|
RU2798838C2 |
| PHENYLCARBAMATES AND USE THEREOF AS ENZYME INHIBITORS OF HYDROLASES OF FATTY ACID AMIDES (FAAH) AND DOPAMINE RECEPTOR D3 (D3DR) MODULATORS | 2014 |
|
RU2693457C2 |
| CASR ANTAGONIST | 2004 |
|
RU2315036C2 |
